[Severe hypercalcemia as a complication of intensive treatment for osteoporosis due to steroid therpay in 17-year-old girl with the nephrotic syndrome].
D000293:Adolescent; D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002118:Calcium / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000009:adverse effects* / Q000627:therapeutic use; D006934:Hypercalcemia / Q000139:chemically induced*; D007049:Iatrogenic Disease; D007669:Kidney Calculi / Q000139:chemically induced; D009402:Nephrosis, Lipoid / Q000188:drug therapy*; D010024:Osteoporosis / Q000139:chemically induced*; D013256:Steroids / Q000008:administration & dosage / Q000009:adverse effects*; D014807:Vitamin D / Q000009:adverse effects / Q000627:therapeutic use
D050071:Bone Density Conservation Agents; D006887:Hydroxycholecalciferols; D013256:Steroids; D014807:Vitamin D; D002118:Calcium; C008088:alfacalcidol
Groźna hiperkalcemia jako powikłanie intensywnego leczenia osteoporozy posterydowej u 17-letniej dziewczynki z zespołem nerczycowym.